Gary D. Glick
Founder, President, CEO & DirectorDr. Gary D. Glick, Ph.D., is Co-Founder of Scorpion Therapeutics, Inc. He is Entrepreneur in Residence of Omega Fund Management, LLC from 2020. Dr. Glick joined the Omega Fund Management, LLC in February 2020. Dr. Glick is Co-Founder & Director of IFM Therapeutics, LLC. Dr. Glick joined the IFM Therapeutics, LLC in 2015. Dr. Glick was Co-Founder, CEO & Director of IFM Therapeutics, LLC. Dr. Glick is Atlas Advisor of Atlas Venture Advisors, Inc. (formerly known as Atlas Venture L.P.). Dr. Glick is Advisor of Delin Ventures Advisors Limited. Dr. Glick is Member of Scientific Advisory Board of Aktis Oncology, Inc. Dr. Glick is Founder of Odyssey Therapeutics, Inc. and has been its President, CEO & Director since April 2021. Dr. Glick was Senior Advisor of Abingworth LLP until 2023. Dr. Glick was Co-Founder of Lycera Corp. Dr. Glick joined the Lycera Corp. in 2006. Dr. Glick was Founder, CEO, President & Director of First Wave Bio, Inc. Dr. Glick has Ph.D. in Organic Chemistry from Columbia University from 1983 to 1988 and B.A. in Chemistry from Rutgers, The State University of New Jersey from 1979 to 1983 and completed an NIH postdoctoral fellowship in organic chemistry at Harvard University.
Positions
- Company NameOdyssey Therapeutics, Inc.Stock CodeODTXPositionFounder, President, CEO & DirectorColleagues
- JMJeffrey Marc LeidenIndependent Chairman of the Board
- JHJason HaasChief Financial Officer
- CTCollin ToddSenior Vice President of Strategy & Business Development
- ELEicke LatzScientific Co-Founder
- KLKim LewisScientific Co-Founder
- SCStephen C. BlacklowChairman of Scientific Advisory Board
- IFIan F. SmithIndependent Director
- VOValerie OdegardIndependent Director
